|Bid||51.700 x 600|
|Ask||51.750 x 400|
|Day's Range||51.100 - 51.800|
|52 Week Range||24.850 - 59.500|
|PE Ratio (TTM)||20.98|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Q2 2017 Advisory Board Co Earnings Call
Before The Advisory Board Co. (ABCO) even began its second-quarter conference call Tuesday, CEO Robert Musslewhite warned analysts he wouldn't be answering questions about the one thing they likely wanted to ask about the most: the company's ongoing review of a possible sale . Musslewhite did, however, agree to very briefly answer a question about how that process has been impacting business at the D.C. health care and education consultancy. The company, which confirmed in February it was courting a possible acquisition, is reportedly mulling the sale of its health division to UnitedHealthcare and higher education division to private equity firm Vista Equity Partners, according to a Bloomberg story last month — a strategy that Wall Street analysts have said would make sense .
The Washington-based company said it had net income of 36 cents per share. Earnings, adjusted for one-time gains and costs, came to 37 cents per share. The results did not meet Wall Street expectations. ...